XML 39 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Text Block [Abstract]  
Stock-Based Compensation Expense on All Employee and Non-Employee Awards

The Company recognized stock-based compensation expense on all employee and non-employee awards as follows:

 

 

 

For the Three Months Ended September 30,

 

 

For the Nine Months Ended September 30,

 

(in thousands)

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Research and development

 

 

535

 

 

 

522

 

 

 

2,115

 

 

 

1,587

 

General and administrative

 

 

1,836

 

 

 

1,270

 

 

 

7,742

 

 

 

3,806

 

Stock-based compensation expense

 

$

2,371

 

 

$

1,792

 

 

$

9,857

 

 

$

5,393

 

Fair Value of Stock Options Assumptions Using Black-Scholes Option Valuation Model

For the three and nine months ended September 30, 2021 and 2020, the fair value of stock options was estimated on the date of grant using a Black-Scholes option valuation model with the following assumptions:

 

 

 

For the Three Months Ended September 30,

 

 

For the Nine Months Ended September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Risk-free interest rate

 

0.89 - 0.96%

 

 

0.36 - 0.39%

 

 

0.50 - 1.15%

 

 

0.36 - 1.68%

 

Expected life in years

 

6.00 - 6.25

 

 

5.75 - 6.25

 

 

5.50 - 6.25

 

 

5.75 - 6.25

 

Expected volatility

 

72.53 - 72.84%

 

 

73.59 - 74.18%

 

 

72.53 - 74.80%

 

 

71.11 - 74.18%

 

Expected dividend yield

 

 

%

 

 

%

 

 

%

 

 

%

Stock Option Activity under Stock Option Plan

Stock option activity under the Company’s stock option plans for the nine months ended September 30, 2021 is as follows:

 

(in thousands, except share and per share data)

 

Number
of Shares

 

 

Weighted-
Average Exercise
Price

 

 

Weighted-
Average
Contractual
Term (Years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding, December 31, 2020

 

 

6,840,719

 

 

$

3.81

 

 

 

 

 

 

 

Granted

 

 

7,150,438

 

 

 

2.97

 

 

 

 

 

 

 

Exercised

 

 

(363,109

)

 

 

2.86

 

 

 

 

 

 

 

Cancelled

 

 

(2,555,154

)

 

 

3.54

 

 

 

 

 

 

 

Outstanding, September 30, 2021

 

 

11,072,894

 

 

$

3.36

 

 

 

8.32

 

 

$

473

 

Options exercisable, September 30, 2021

 

 

5,743,820

 

 

$

4.08

 

 

 

7.24

 

 

$

 

Options exercisable, December 31, 2020

 

 

3,596,315

 

 

$

4.17

 

 

 

6.90

 

 

$

598

 

Options available for future grant

 

 

2,224,159

 

 

 

 

 

 

 

 

 

 

Summary of Unvested Restricted Stock

A summary of the status of unvested restricted stock for the nine months ended September 30, 2021 is as follows:

 

 

 

Number of Shares

 

 

Weighted-Average
Grant Date Fair Value

 

Unvested, December 31, 2020

 

 

786,280

 

 

$

3.08

 

Granted

 

 

1,601,224

 

 

 

2.60

 

Vested

 

 

(466,436

)

 

 

3.68

 

Cancelled

 

 

(410,413

)

 

 

3.46

 

Unvested, September 30, 2021

 

 

1,510,655

 

 

$

2.28